Author: Pahar, Bapi; Madonna, Stefania; Das, Arpita; Albanesi, Cristina; Girolomoni, Giampiero
Title: Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections Cord-id: lf4vlpb5 Document date: 2020_9_10
ID: lf4vlpb5
Snippet: Antimicrobial peptides (AMPs) are produced by neutrophils, monocytes, and macrophages, as well as epithelial cells, and are an essential component of innate immunity system against infection, including several viral infections. AMPs, in particular the cathelicidin LL-37, also exert numerous immunomodulatory activities by inducing cytokine production and attracting and regulating the activity of immune cells. AMPs are scarcely expressed in normal skin, but their expression increases when skin is
Document: Antimicrobial peptides (AMPs) are produced by neutrophils, monocytes, and macrophages, as well as epithelial cells, and are an essential component of innate immunity system against infection, including several viral infections. AMPs, in particular the cathelicidin LL-37, also exert numerous immunomodulatory activities by inducing cytokine production and attracting and regulating the activity of immune cells. AMPs are scarcely expressed in normal skin, but their expression increases when skin is injured by external factors, such as trauma, inflammation, or infection. LL-37 complexed to self-DNA acts as autoantigen in psoriasis and lupus erythematosus (LE), where it also induces production of interferon by plasmocytoid dendritic cells and thus initiates a cascade of autocrine and paracrine processes, leading to a disease state. In these disorders, epidermal keratinocytes express high amounts of AMPs, which can lead to uncontrolled inflammation. Similarly, LL-37 had several favorable and unfavorable roles in virus replication and disease pathogenesis. Targeting the antiviral and immunomodulatory functions of LL-37 opens a new approach to limit virus dissemination and the progression of disease.
Search related documents:
Co phrase search for related documents- aberrant expression and activating protease: 1
- aberrant expression and activation release: 1, 2
- aberrant expression and acute respiratory syndrome: 1, 2, 3, 4
- aberrant expression and adaptive immunity: 1
- aberrant expression and adaptive immunity innate: 1
- aberrant expression and adaptive innate: 1, 2, 3, 4
- aberrant expression and liver disease: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date